176 related articles for article (PubMed ID: 34478444)
1. Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi.
Versteeg L; Adhikari R; Poveda C; Villar-Mondragon MJ; Jones KM; Hotez PJ; Bottazzi ME; Tijhaar E; Pollet J
PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009689. PubMed ID: 34478444
[TBL] [Abstract][Full Text] [Related]
2. A novel multi-epitope recombinant protein elicits an antigen-specific CD8+ T cells response in Trypanosoma cruzi-infected mice.
González-López C; Chen WH; Alfaro-Chacón A; Villanueva-Lizama LE; Rosado-Vallado M; Ramirez-Sierra MJ; Teh-Poot CF; Pollet J; Asojo O; Jones KM; Hotez PJ; Elena Bottazzi M; Cruz-Chan JV
Vaccine; 2022 Oct; 40(45):6445-6449. PubMed ID: 36184402
[TBL] [Abstract][Full Text] [Related]
3. Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
Dzul-Huchim VM; Ramirez-Sierra MJ; Martinez-Vega PP; Rosado-Vallado ME; Arana-Argaez VE; Ortega-Lopez J; Gusovsky F; Dumonteil E; Cruz-Chan JV; Hotez P; Bottazzi ME; Villanueva-Lizama LE
PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010258. PubMed ID: 36095001
[TBL] [Abstract][Full Text] [Related]
4. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
Seid CA; Jones KM; Pollet J; Keegan B; Hudspeth E; Hammond M; Wei J; McAtee CP; Versteeg L; Gutierrez A; Liu Z; Zhan B; Respress JL; Strych U; Bottazzi ME; Hotez PJ
Hum Vaccin Immunother; 2017 Mar; 13(3):621-633. PubMed ID: 27737611
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
[TBL] [Abstract][Full Text] [Related]
6. Characterization and Stability of Trypanosoma cruzi 24-C4 (Tc24-C4), a Candidate Antigen for a Therapeutic Vaccine Against Chagas Disease.
Biter AB; Weltje S; Hudspeth EM; Seid CA; McAtee CP; Chen WH; Pollet JB; Strych U; Hotez PJ; Bottazzi ME
J Pharm Sci; 2018 May; 107(5):1468-1473. PubMed ID: 29274820
[TBL] [Abstract][Full Text] [Related]
7. Trypanosoma cruzi Tc24 Antigen Expressed and Orally Delivered by Schizochytrium sp. Microalga is Immunogenic in Mice.
Ramos-Vega A; Monreal-Escalante E; Rosales-Mendoza S; Bañuelos-Hernández B; Dumonteil E; Angulo C
Mol Biotechnol; 2024 Jun; 66(6):1376-1388. PubMed ID: 37344711
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a recombinant vaccine against Trypanosoma cruzi in Rhesus macaques.
Dumonteil E; Herrera C; Tu W; Goff K; Fahlberg M; Haupt E; Kaur A; Marx PA; Ortega-Lopez J; Hotez PJ; Bottazzi ME
Vaccine; 2020 Jun; 38(29):4584-4591. PubMed ID: 32417142
[TBL] [Abstract][Full Text] [Related]
9. Covalent vaccination with Trypanosoma cruzi Tc24 induces catalytic antibody production.
Gunter SM; Versteeg L; Jones KM; Keegan BP; Strych U; Bottazzi ME; Hotez PJ; Brown EL
Parasite Immunol; 2018 Nov; 40(11):e12585. PubMed ID: 30132929
[TBL] [Abstract][Full Text] [Related]
10. Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.
Gunter SM; Jones KM; Seid CA; Essigmann HT; Zhan B; Strych U; Bottazzi ME; Hotez PJ; Brown EL
J Parasitol; 2017 Oct; 103(5):579-583. PubMed ID: 28581897
[TBL] [Abstract][Full Text] [Related]
11. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
[TBL] [Abstract][Full Text] [Related]
12. A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection.
Barry MA; Versteeg L; Wang Q; Pollet J; Zhan B; Gusovsky F; Bottazzi ME; Hotez PJ; Jones KM
PLoS Negl Trop Dis; 2019 May; 13(5):e0007413. PubMed ID: 31145733
[TBL] [Abstract][Full Text] [Related]
13. Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24.
Gunter SM; Jones KM; Zhan B; Essigmann HT; Murray KO; Garcia MN; Gorchakov R; Bottazzi ME; Hotez PJ; Brown EL
Am J Trop Med Hyg; 2016 Jan; 94(1):114-121. PubMed ID: 26598565
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.
Dumonteil E; Escobedo-Ortegon J; Reyes-Rodriguez N; Arjona-Torres A; Ramirez-Sierra MJ
Infect Immun; 2004 Jan; 72(1):46-53. PubMed ID: 14688079
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease.
Jones KM; Mangin EN; Reynolds CL; Villanueva LE; Cruz JV; Versteeg L; Keegan B; Kendricks A; Pollet J; Gusovsky F; Bottazzi ME; Hotez PJ
Front Cell Infect Microbiol; 2023; 13():1106315. PubMed ID: 36844399
[TBL] [Abstract][Full Text] [Related]
16. Vaccine-linked chemotherapy induces IL-17 production and reduces cardiac pathology during acute Trypanosoma cruzi infection.
Cruz-Chan JV; Villanueva-Lizama LE; Versteeg L; Damania A; Villar MJ; González-López C; Keegan B; Pollet J; Gusovsky F; Hotez PJ; Bottazzi ME; Jones KM
Sci Rep; 2021 Feb; 11(1):3222. PubMed ID: 33547365
[TBL] [Abstract][Full Text] [Related]
17. Trypanosoma cruzi: analysis of cellular and humoral response against a protective recombinant antigen during experimental Chagas' disease.
Taibi A; Espinoza AG; Ouaissi A
Immunol Lett; 1995 Dec; 48(3):193-200. PubMed ID: 8867851
[TBL] [Abstract][Full Text] [Related]
18. Protective efficacy of the oral vaccine Tc24:Co1 produced in Schizochytrium sp. against Trypanosoma cruzi infection in a mouse model.
Ramos-Vega A; Dzul-Huchim VM; Villanueva-Lizama LE; Dumonteil E; Rosales-Mendoza S; Bañuelos-Hernández B; Angulo M; Cruz-Chan JV; Monreal-Escalante E; Angulo C
Microb Pathog; 2024 Jan; 186():106488. PubMed ID: 38061668
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
[TBL] [Abstract][Full Text] [Related]
20. Comparative evaluation of therapeutic DNA vaccines against Trypanosoma cruzi in mice.
Sanchez-Burgos G; Mezquita-Vega RG; Escobedo-Ortegon J; Ramirez-Sierra MJ; Arjona-Torres A; Ouaissi A; Rodrigues MM; Dumonteil E
FEMS Immunol Med Microbiol; 2007 Aug; 50(3):333-41. PubMed ID: 17521394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
